A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to assess long-term safety and tolerability of
Edivoxetine in pediatric participants with attention deficit hyperactive disorder (ADHD).